Marimed (MRMD) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Marimed (MRMD) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | 5.84% |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | -11.73% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | 7.65% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.86% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 27.15% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -6.48% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 11.32% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.90% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 28.35% |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 3.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.19% |
| Mar 31, 2026 | 6.10% |
| Dec 31, 2025 | 7.66% |
| Sep 30, 2025 | 9.04% |
| Jun 30, 2025 | 10.25% |
| Mar 31, 2025 | 12.96% |
| Dec 31, 2024 | 14.86% |
| Sep 30, 2024 | 17.07% |
| Jun 30, 2024 | 21.29% |
| Mar 31, 2024 | 24.10% |
| Dec 31, 2023 | 24.99% |
| Sep 30, 2023 | 23.25% |
| Jun 30, 2023 | 20.79% |
| Mar 31, 2023 | 19.06% |
| Dec 31, 2022 | 18.74% |
| Sep 30, 2022 | 20.57% |
| Jun 30, 2022 | 22.50% |
| Mar 31, 2022 | 22.73% |
| Dec 31, 2021 | 22.15% |
| Jun 30, 2021 | 18.86% |